A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
University Hospital, Ghent
Sun Yat-sen University
National Institutes of Health Clinical Center (CC)
Herlev Hospital
Vejle Hospital
The Christie NHS Foundation Trust
Vejle Hospital
Peking University
National Health Research Institutes, Taiwan
Fondazione del Piemonte per l'Oncologia
Rigshospitalet, Denmark